With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
It is time to take a look at the 2016 stock buyback kings, those companies that will spend the most buying back their common stock this year alone.
February 5, 2016: Markets opened lower on Friday following a lower-than-expected report on nonfarm payrolls. There appears to be some concern that investors are worried about the impact of the payroll report…
Johnson & Johnson reported its fourth-quarter financial results before the markets opened on Tuesday.
Chris Lange Johnson & Johnson is set to release its fourth-quarter financial results before the markets open Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies (and others) that are reporting their quarterly results this week.
Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if the market keeps drifting south.
Johnson & Johnson is looking to save some money over the next few years and as a result it is taking action by restructuring its Medical Devices businesses.
Chris Lange 24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case for each in 2016.
ThinkstockIn the second quarter of this year, U.S. corporate profits totalled $1.8 trillion after taxes. Massive corporate profit is not limited to the United States, although many of the world’s most profitable…
ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or leiomyosarcoma (LMS) who received a prior…
Chris Lange ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech stocks continue to get new life, helping overcome some softness in tech…
Johnson & Johnson reported mixed third-quarter 2015 results before markets opened Tuesday morning.
Paul Ausick Johnson & Johnson is scheduled to report its third-quarter financial results before the markets open on Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies that are reporting their quarterly results this week.
